Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects

Antipsychotic drugs targeting dopamine neurotransmission are still the principal mean of therapeutic intervention for schizophrenia. However, about one third of people do not respond to dopaminergic antipsychotics. Genome wide association studies (GWAS), have shown that multiple genetic factors play...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampino, Antonio, Marakhovskaia, Aleksandra, Soares-Silva, Tiago, Torretta, Silvia, Veneziani, Federica, Beaulieu, Jean Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338030/
https://www.ncbi.nlm.nih.gov/pubmed/30687136
http://dx.doi.org/10.3389/fpsyt.2018.00702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338030/
https://www.ncbi.nlm.nih.gov/pubmed/30687136
http://dx.doi.org/10.3389/fpsyt.2018.00702

Ejemplares similares